{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:52:53Z","timestamp":1782895973627,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jacc.2023.02.027","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T13:58:49Z","timestamp":1681135129000},"page":"1459-1470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Heart\u00a0Failure Following Anti-Inflammatory\u00a0Medications in Patients\u00a0With Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8196-2599","authenticated-orcid":false,"given":"Anders","family":"Holt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1803-5266","authenticated-orcid":false,"given":"Jarl E.","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4891-7358","authenticated-orcid":false,"given":"Nina","family":"Nouhravesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian Kinnberg","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam Elmegaard","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Schjerning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacc.2023.02.027_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jacc.2023.02.027_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12933-021-01408-1","article-title":"Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management","volume":"20","author":"Ceriello","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.jacc.2023.02.027_bib3","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jacc.2023.02.027_bib4","doi-asserted-by":"crossref","first-page":"i4857","DOI":"10.1136\/bmj.i4857","article-title":"Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study","volume":"354","author":"Arf\u00e8","year":"2016","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.jacc.2023.02.027_bib5","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacc.2023.02.027_bib6","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejheart.2008.07.013","article-title":"Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials","volume":"10","author":"Scott","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"26","key":"10.1016\/j.jacc.2023.02.027_bib7","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jacc.2023.02.027_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ehjcvp\/pvv054","article-title":"Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: Review and position paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"2","author":"Schmidt","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"9894","key":"10.1016\/j.jacc.2023.02.027_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Baigent","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jacc.2023.02.027_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.jacc.2023.02.027_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes: global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2019","journal-title":"J\u00a0Epidemiol Glob Health"},{"issue":"2","key":"10.1016\/j.jacc.2023.02.027_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001388","article-title":"Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries","volume":"10","author":"McGettigan","year":"2013","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.jacc.2023.02.027_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The\u00a0Danish Civil Registration System as a tool in\u00a0epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2023.02.027_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"7 Suppl","key":"10.1016\/j.jacc.2023.02.027_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"6","key":"10.1016\/j.jacc.2023.02.027_bib16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/M21-3445","article-title":"Adverse events associated with coprescription of phosphodiesterase type 5 inhibitors and oral organic nitrates in male patients with ischemic heart disease","volume":"175","author":"Holt","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.jacc.2023.02.027_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jacc.2023.02.027_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.amjmed.2021.11.008","article-title":"Bleeding risk following systemic fluconazole or topical azoles in patients with atrial fibrillation on apixaban, rivaroxaban, or dabigatran","volume":"135","author":"Holt","year":"2022","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.jacc.2023.02.027_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kww079","article-title":"Persistent user bias in case-crossover studies in pharmacoepidemiology","volume":"184","author":"Hallas","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2023.02.027_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2147\/CLEP.S311450","article-title":"The validity of Danish Prescription data to measure use of aspirin and other non-steroidal anti-inflammatory drugs and quantification of bias due to non-prescription drug use","volume":"13","author":"Gaster","year":"2021","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jacc.2023.02.027_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12325-021-01939-9","article-title":"Drug interactions affecting kidney function: beware of health threats from triple whammy","volume":"39","author":"Har\u0119\u017clak","year":"2022","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.jacc.2023.02.027_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.0006-341X.2000.00554.x","article-title":"Nonparametric analysis of recurrent events and death","volume":"56","author":"Ghosh","year":"2000","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.jacc.2023.02.027_bib23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/rssc.12350","article-title":"The mean, variance and correlation for bivariate recurrent event data with a terminal event","volume":"68","author":"Scheike","year":"2019","journal-title":"J\u00a0R Stat Soc Ser C (Applied Stat)"},{"issue":"6","key":"10.1016\/j.jacc.2023.02.027_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/pds.5227","article-title":"Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology","volume":"30","author":"Cadarette","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.jacc.2023.02.027_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2023.02.027_bib26","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.r-project.org\/ (June 29, 2022)."},{"issue":"6","key":"10.1016\/j.jacc.2023.02.027_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.jacc.2023.02.027_bib28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2307\/2532098","article-title":"Estimates of absolute cause-specific risk in cohort studies","volume":"46","author":"Benichou","year":"1990","journal-title":"Biometrics"},{"issue":"5","key":"10.1016\/j.jacc.2023.02.027_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1479164116645583","article-title":"Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics","volume":"13","author":"J\u00f8rgensen","year":"2016","journal-title":"Diabetes Vasc Dis Res"},{"issue":"36","key":"10.1016\/j.jacc.2023.02.027_bib30","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723004217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723004217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:56:19Z","timestamp":1760018179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109723004217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":30,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0735109723004217"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2023.02.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742615583.793601173","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart\u00a0Failure Following Anti-Inflammatory\u00a0Medications in Patients\u00a0With Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}